CAS RN: 552846-17-0
1-(tert-Butoxycarbonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250119 |
1g / 5g / 25g / 100g / 500g |
Confirm by inquiry |
Shanghai, Shandong | 5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 5g, 10g, 25g, 100g, 500g, 1000g
- Available purity: >97%
- Inventory rows with stock: 5
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 552846-17-0
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
>97% |
5
In Stock
|
Hong Kong |
Inquiry |
| 5g |
>97% |
5
In Stock
|
Beijing |
Inquiry |
| 10g |
>97% |
5
In Stock
|
Shanghai |
Inquiry |
| 25g |
>97% |
5
In Stock
|
Hong Kong |
Inquiry |
| 100g |
>97% |
5
In Stock
|
Hong Kong |
Inquiry |
| 500g |
>97% |
0
Out of Stock
|
Shenzhen |
Inquiry |
| 1000g |
>97% |
0
Out of Stock
|
Shenzhen |
Inquiry |
552846-17-0 / tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate
Standard CAS: 552846-17-0
Multi CAS: No
Basic Information
CAS
552846-17-0
Multi CAS
No
Molecular Formula
BC14H23N2O4
Molecular Weight
294.160000
Exact Mass
294.175087
InChI
InChI=1S/C14H23BN2O4/c1-12(2,3)19-11(18)17-9-10(8-16-17)15-20-13(4,5)14(6,7)21-15/h8-9H,1-7H3
InChIKey
IPISOFJLWYBCAV-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
21
Aromatic heavy atom count
5
Fraction Csp3
0.71
Rotatable bonds
1
H-bond acceptors
6
Molar refractivity
79.58
TPSA
62.58
LogP / Solubility
WLOGP
1.97
MLOGP
1.74
XLogP3
1.97
Consensus LogP
1.89
Log S (ESOL)
-3.01
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.39
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3.32
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.12
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
2.5